IRIS
MESSINA, Sonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.781
NA - Nord America 10.515
AS - Asia 6.999
SA - Sud America 3.042
AF - Africa 224
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 33.596
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.239
RU - Federazione Russa 6.603
SG - Singapore 2.904
BR - Brasile 2.625
CN - Cina 1.970
IE - Irlanda 1.674
SE - Svezia 998
IT - Italia 807
HK - Hong Kong 730
DE - Germania 531
VN - Vietnam 488
PL - Polonia 477
FR - Francia 457
FI - Finlandia 365
UA - Ucraina 350
GB - Regno Unito 257
IN - India 208
AR - Argentina 156
BD - Bangladesh 104
MX - Messico 101
CA - Canada 97
IQ - Iraq 79
TR - Turchia 78
EC - Ecuador 74
ID - Indonesia 64
ZA - Sudafrica 64
AT - Austria 51
NL - Olanda 51
MA - Marocco 45
UZ - Uzbekistan 45
VE - Venezuela 45
BE - Belgio 41
PK - Pakistan 39
CO - Colombia 38
JP - Giappone 38
PY - Paraguay 31
CL - Cile 26
KE - Kenya 26
ES - Italia 25
CI - Costa d'Avorio 24
TN - Tunisia 22
PE - Perù 20
PH - Filippine 20
JO - Giordania 19
CR - Costa Rica 18
IL - Israele 18
SA - Arabia Saudita 18
AE - Emirati Arabi Uniti 17
UY - Uruguay 17
AZ - Azerbaigian 16
CZ - Repubblica Ceca 16
KZ - Kazakistan 16
MY - Malesia 16
NP - Nepal 16
EG - Egitto 15
JM - Giamaica 13
IR - Iran 12
LT - Lituania 12
OM - Oman 12
PA - Panama 12
DO - Repubblica Dominicana 11
EU - Europa 11
NZ - Nuova Zelanda 10
PS - Palestinian Territory 10
AU - Australia 9
DZ - Algeria 9
LB - Libano 9
NI - Nicaragua 9
PT - Portogallo 9
AL - Albania 8
BO - Bolivia 8
KW - Kuwait 7
RS - Serbia 7
AO - Angola 6
HN - Honduras 6
RO - Romania 6
HU - Ungheria 5
KR - Corea 5
LK - Sri Lanka 5
QA - Qatar 5
CY - Cipro 4
HR - Croazia 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
GT - Guatemala 3
NG - Nigeria 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
AM - Armenia 2
CH - Svizzera 2
GA - Gabon 2
GR - Grecia 2
GY - Guiana 2
KG - Kirghizistan 2
Totale 33.563
Salva come PNG Salva come JPEG
Città #
Moscow 2.091
Dublin 1.668
Ashburn 1.522
Singapore 1.494
Dallas 1.130
Chandler 1.055
Jacksonville 795
Hong Kong 730
Beijing 725
Nyköping 568
Warsaw 460
The Dalles 402
San Jose 395
Princeton 363
Medford 307
Lauterbourg 283
Cambridge 260
Los Angeles 243
Des Moines 219
Ann Arbor 210
Messina 189
Dearborn 182
São Paulo 173
Ho Chi Minh City 157
Boardman 147
Buffalo 147
Munich 126
New York 106
San Mateo 94
Lancaster 92
Hanoi 91
Council Bluffs 90
Tianjin 89
Redondo Beach 88
Rio de Janeiro 78
Shenyang 75
Wilmington 72
Jinan 71
Pune 70
Rome 70
Bremen 67
Turku 64
Guangzhou 62
Belo Horizonte 57
Frankfurt am Main 56
Nanjing 54
Brasília 52
Houston 50
Orem 48
Curitiba 46
Porto Alegre 46
Woodbridge 45
Tashkent 43
Baghdad 38
Brussels 38
Dong Ket 38
Nuremberg 37
Santa Clara 37
Hangzhou 36
Chennai 35
Tokyo 35
Brooklyn 33
Campinas 33
Zhengzhou 33
Guarulhos 32
Hebei 32
Ningbo 32
Shanghai 29
Vienna 28
Johannesburg 27
Ribeirão Preto 26
Seattle 26
Toronto 26
Atlanta 25
Guayaquil 25
Helsinki 25
Jakarta 25
Quito 25
Abidjan 24
Amsterdam 23
Haikou 23
Milan 23
Taizhou 22
Lappeenranta 21
Mexico City 21
Montreal 21
Stockholm 21
London 20
Nairobi 20
Nanchang 20
Salvador 20
San Francisco 20
Sorocaba 20
São José do Rio Preto 20
Changsha 19
Fortaleza 19
Joinville 19
Juiz de Fora 19
Norwalk 19
Shenzhen 19
Totale 19.046
Salva come PNG Salva come JPEG
Nome #
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 251
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 224
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 210
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 199
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 198
A new form of alpha-dystroglycanopathy associated with severe drug-resistant epilepsy and unusual EEG features 195
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 194
Alexithymia, burden and resilience in ALS’ caregivers 193
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 191
Effect of exercise on telomere length and telomere proteins expression in mdx mice 188
Autonomic nervous system involvement in spinal muscular atrophy. 187
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 187
Hippo signaling pathway is altered in Duchenne muscular dystrophy 187
Nusinersen versus sham control in later-onset spinal muscular atrophy 186
An observational study of functional abilities in infants, children, and adults with type 1 SMA 181
ANT1 is reduced in sporadic inclusion body myositis. 177
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 176
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 176
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 175
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 175
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes 171
Pilot study of flavocoxid in ambulant DMD patients. 169
Pilot study of serial casting of ankles in muscular dystrophy patients. 167
Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis 167
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 166
Apoptosis and apoptosis-related proteins in thyroid myopathies 165
Pilot study of serial casting in muscular dystrophy patients. 165
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 164
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 163
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 161
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 160
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 158
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 158
Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study. 157
Impaired myocardial deformation revealing subclinical left ventricular dysfunction in children with Duchenne dystrophy: a speckle tracking echocardiography study 156
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 156
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 156
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 155
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 155
Age and baseline values predict 12 and 24-month functional changes in type 2 SMA 155
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 154
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 154
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy 154
The 24-month PUL changes and steroids correlation. 153
A comprehensive molecular approach in COLA6 related myopathies based on genomic sequencing, transcriptional analysis and array CGH. 152
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 152
Genomic Variations Affecting Biological Effects of Statins 151
24-Holter ECG in type II and III SMA 150
Pilot study of flavocoxid in ambulant DMD patients. 150
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 150
Pilot study of flavocoxid in ambulant DMD patients. 150
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 149
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 149
Severe rhabdomyolysis in a patient with “Heat Stroke” 148
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 147
Burden, social network and professional support in the families of patients with muscular dystrophies: results from the GUP10002 study. 146
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 146
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy 146
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 145
Clinical variability in spinal muscular atrophy type III 144
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 144
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes 142
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 142
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 142
Development of an academic disease registry for spinal muscular atrophy 142
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy 141
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 141
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 141
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 140
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care? 140
Conceptualizing the relations between metacognition and executive functions in Amyotrophic Lateral Sclerosis (ALS) patients’ caregivers. A preliminary study 139
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 137
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data 137
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies in the UK and differences with the Italian population 136
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 136
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 135
Teriparatide (rhPTH) treatment in Duchenne Muscular Dystrophy, a case report. 135
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 135
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data 135
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 133
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 132
Expression of the trascription factor NFkB in different muscular dystrophies 131
6 min walking test 12 month changes in DMD: Correlation with genotype. 130
Timed rise from floor as a predictor of disease progression in Duchenne muscular dystrophy: An observational study 130
A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review 129
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with neuromuscolar disorders: a speckle tracking study 129
study of flavocoxid in ambulant DMD patients. 129
Histological effects of givinostat in boys with Duchenne muscular dystrophy 129
Implication of SIRT1 and its downstream pathways in dystrophic process. 129
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 128
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 127
The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability. 127
Bone quality in Duchenne muscular dystrophy 127
Muscle Fat-Fraction and Mapping in Duchenne Muscular Dystrophy: Evaluation of Disease Distribution and Correlation with Clinical Assessments: A preliminary experience. 122
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 122
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies: Analysis of the UK diagnostic service 2001-2013. 122
Pilot study of flavocoxid in ambulant DMD patients. 121
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 119
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 119
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. 118
Totale 15.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 0 0 0 0 0 0 0 90
2021/20221.688 9 123 13 113 97 14 125 71 51 116 211 745
2022/20234.386 391 318 161 309 379 382 29 236 1.999 21 122 39
2023/20241.108 84 200 73 100 112 214 46 31 16 43 28 161
2024/20255.731 98 76 102 350 246 151 161 1.365 1.509 327 431 915
2025/202616.129 694 1.196 1.308 1.300 1.184 3.515 1.894 1.877 1.907 708 335 211
Totale 34.206